Centene Corporation (CNC)

NYSE · Health Care · market cap 29.43B

Share price

$66.53

At the last nightly close

Intrinsic value

$111.62

Range $111.62 – $189.63 — the conservative figure is the low end.

Margin of safety

+67.8%

($111.62 − $66.53) ÷ $66.53

EV / EBIT

26.2

On the median operating profit of 15 fiscal years through 2025.

How these numbers are computed

The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above starts from the lower of the first two; the Graham Number never enters it.

The frame gives no credit for growth unless the company has earned it: only a return on invested capital that has beaten the cost of capital year after year earns a growth credit, and that credit is capped. A company that compounds will therefore usually read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.

The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.

Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-11-03.

Key metrics

Price / earnings22.9
Price / book1.5
EV / EBITDA5.5
FCF / EV+3.2%
Return on equity+6.7%
Return on assets+2.7%
Debt / equity0.70
Gross margin+11.3%

Market position

52-week high$71.24
52-week low$31.80
From 52-week high-6.6%
RSI (14)47.0
200-day moving average$57.58

Annual financials

PeriodRevenueOperating incomeNet incomeEPSFree cash flow
2025-FY194.78B-312.0M-6.67B-13.534.32B
2024-FY163.07B3.19B3.31B6.33-490.0M
2023-FY154.00B3.46B2.70B4.977.25B
2022-FY144.55B3.64B1.20B2.095.26B
2021-FY125.98B1.78B1.35B2.283.29B

Filed figures from SEC EDGAR, in the reporting currency.

Next earnings

Q1 2027 expectedFebruary 5, 2027
Consensus EPS estimate-1.12

Recent news

The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on CNC.

Run the board on CNC

10 free analyses · no signup, no card

This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.